We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

H3 Biomedicine and Selvita Extend Precision Cancer Medicines Collaboration

News   Sep 23, 2015

 
H3 Biomedicine and Selvita Extend Precision Cancer Medicines Collaboration
 
 
Advertisement
 

RELATED ARTICLES

HER2 Breast Cancer Cells Adopt Strategy To Resist Immunotherapy

News

Findings from a study published in Nature Communications reveal how cancer cells escape death by lymphocytes through the disruption of interferon-gamma signaling.

READ MORE

Compound Repairs Degenerating Brain Cells in ALS

News

Scientists have identified a compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to the neurodegenerative disease amyotrophic lateral sclerosis (ALS)

READ MORE

Team Develops Glioma-Targeted Anticancer Drug

News

Glioblastoma multiforme is a common and aggressive form of primary brain tumor that is particularly hard to treat. However, researchers now report a new glioma-targeted nano-therapeutic that will only address tumor cells offering increased effectiveness and reduced side effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE